—
The Global Insomnia Market - Market Research Analysis 2015-2019 report, vendors are entering into strategic alliances with other vendors and universities for the research, development, manufacture, and distribution of drugs. The trend is predicted to continue during the forecast period.The Complete Global Insomnia Market - Market Research Analysis 2015 – 2019 is available at http://www.reportsnreports.com/reports/425066-global-insomnia-market-market-research-analysis-2015-2019.html. The report is of 62 pages that come with 255 Exhibits that support the market research.
The analysts forecast global insomnia market to decline at a CAGR of 3.08% over the period 2014-2019.
According to the Global Insomnia Market - Market Research Analysis 2015 – 2019 report, People's growing awareness of the importance of sleep will motivate individuals with insomnia to seek treatment. The low diagnosis rate for insomnia is due to the lack of awareness and identification of symptoms. Therefore, awareness campaigns and initiatives by hospitals and healthcare centers will help people understand the consequences of sleep disturbances and motivate them to seek treatment, thus driving the global insomnia drugs market.
Further, the report states that the branded drugs indicated for insomnia are expected to lose their patents during the forecast period. Patent expiry is poised to impact the market significantly by slowing down the market's growth rate.
The following companies are the key players in the Global Insomnia Market: Eisai, Merck, Pfizer, Sanofi and Takeda.
Other Prominent Vendors in the market are: Astellas, Biocodex, ECR Pharmaceuticals, Dainippon Sumitomo, Fidia Farmaceutici, Flynn Pharma, Johnson & Johnson, Juste, Meda, Medice Arzneimittel Putter, Minerva Neurosciences, Neurim, Pernix Therapeutics, Purdue Pharma, SkyePharma, Somnus Therapeutics, Paratek Pharmaceuticals, and Vanda Pharmaceuticals.
The report includes the present scenario and the growth prospects of the global insomnia market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of insomnia.
Order a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=425066. The Single User Cost of the report is US $2500.
The report, Global Insomnia Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.
Key market driver
• Unmet medical needs
• For a full, detailed list, view our report
Key market challenge
• Dominance of generic products
• For a full, detailed list, view our report
Key market trend
• Emerging drugs targeting orexin receptors
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global insomnia drugs market 2014-2019 ($ billions)
Exhibit 03: Key performance indicators of global insomnia drugs market
Exhibit 04: Five forces analysis
Exhibit 05: Pipeline portfolio
Exhibit 06: Market segmentation by type of formulation
Exhibit 07: Market segmentation by symptom
Exhibit 08: Geographical segmentation 2014
Exhibit 09: Global insomnia drugs market: Key drivers
Exhibit 10: Impact of drivers
Exhibit 11: Global insomnia drugs market: Key challenges
Exhibit 12: Impact of drivers and challenges
Exhibit 13: Global insomnia drugs market: Emerging trends
Exhibit 14: Lunesta sales in North America 2011-2014 ($ millions)
Exhibit 15: Lunesta sales in Japan 2013-2014 ($ millions)
Exhibit 16: Ambien: Global sales 2011-2014 ($ millions)
Exhibit 17: Ambien sales in Western Europe 2011-2014 ($ millions)
Exhibit 18: Ambien sales in the US 2011-2014 ($ millions)
Exhibit 19: Ambien sales in emerging markets 2011-2014 ($ millions)
Exhibit 20: Ambien sales in ROW 2011-2014 ($ millions)
Exhibit 21: Rozerem: Global sales 2011-2013 ($ millions)
Exhibit 22: Rozerem sales in Japan 2012-2014 ($ millions)
Exhibit 23: Takeda: Business segmentation by revenue 2015
Exhibit 24: Takeda: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 25: Takeda: Geographical segmentation by revenue 2015
Explore other new reports by Infiniti Research at http://www.reportsnreports.com/publisher/infiniti-research-limited/.
About US:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email, the details on sales at reportsandreports.com.
Contact Info:
Name: Ritesh
Email: Send Email
Organization: ReportsnReports.com
Phone: + 1 888 391 5441
Website: http://www.reportsnreports.com/reports/425066-global-insomnia-market-market-research-analysis-2015-2019.html
Release ID: 92095
Google
RSS